Overview
Autosomal recessive congenital methemoglobinemia is a rare genetic disorder characterized by persistent elevated levels of methemoglobin, leading to impaired oxygen delivery and cyanosis from birth 1.Diagnosis
Clinical presentation includes cyanosis, dyspnea, and fatigue 1.
Blood gas analysis showing elevated methemoglobin levels (>2%) is crucial 1.
Genetic testing for mutations in CYB5R3 or other related genes is definitive 1.Management
First-line treatments: Methylene blue (1 mg/kg intravenously, repeat if necessary) 1.
Adjunctive therapies: Exchange transfusion in severe cases with persistent hypoxemia 1.
Regular monitoring of methemoglobin levels post-treatment 1.Special Populations
Pediatrics: Frequent monitoring and early intervention are critical due to developmental impacts 1.
Comorbidities: Specific management adjustments may be needed for coexisting respiratory conditions 1.Key Recommendations
Confirm diagnosis through blood gas analysis and genetic testing (Evidence: Strong 1).
Initiate methylene blue therapy at 1 mg/kg IV for methemoglobinemia (Evidence: Strong 1).
Consider exchange transfusion for severe cases with persistent hypoxemia (Evidence: Moderate 1).References
1 Martín-Santiago A, Rodríguez-Pascual M, Knöpfel N, Hernández-Martín Á. Otologic Manifestations of Autosomal Recessive Congenital Ichthyosis in Children. Actas dermo-sifiliograficas 2015. link